| Primary |
| Carcinoid Tumour |
13.7% |
| Pancreatic Neuroendocrine Tumour |
13.4% |
| Asthenopia |
10.1% |
| Tuberous Sclerosis |
9.4% |
| Hepatic Neoplasm Malignant |
9.0% |
| Lymphangioleiomyomatosis |
5.8% |
| Diabetes Mellitus |
5.1% |
| Pain |
5.1% |
| Rash |
3.2% |
| Headache |
2.9% |
| Renal Cancer Metastatic |
2.9% |
| Gastritis Prophylaxis |
2.5% |
| Hypertension |
2.5% |
| Metastases To Bone |
2.5% |
| Squamous Cell Carcinoma |
2.5% |
| Colon Cancer |
2.2% |
| Contraception |
2.2% |
| Convulsion |
2.2% |
| Breast Cancer Metastatic |
1.4% |
| Gastrinoma |
1.4% |
|
| Vomiting |
11.9% |
| Pneumonia |
9.5% |
| Vertigo Positional |
9.5% |
| Angioedema |
7.1% |
| Cholelithiasis |
7.1% |
| Oedema Peripheral |
7.1% |
| Pain |
7.1% |
| Gastritis Erosive |
4.8% |
| Musculoskeletal Pain |
4.8% |
| Renal Failure Acute |
4.8% |
| White Blood Cell Count Increased |
4.8% |
| Abdominal Distension |
2.4% |
| Abdominal Pain Lower |
2.4% |
| Abdominal Pain Upper |
2.4% |
| Asthma |
2.4% |
| Cardio-respiratory Arrest |
2.4% |
| Complex Regional Pain Syndrome |
2.4% |
| Death |
2.4% |
| General Physical Health Deterioration |
2.4% |
| Hypokalaemia |
2.4% |
|
| Secondary |
| Pancreatic Neuroendocrine Tumour |
16.4% |
| Rash |
11.0% |
| Rhinitis Allergic |
9.4% |
| Pyrexia |
6.3% |
| Insomnia |
6.2% |
| Drug Use For Unknown Indication |
6.1% |
| Breast Cancer |
4.1% |
| Tuberous Sclerosis |
3.9% |
| Pancreatitis Chronic |
3.8% |
| Headache |
3.7% |
| Carcinoid Tumour |
3.4% |
| Back Pain |
3.1% |
| Constipation |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Onychomycosis |
3.1% |
| Reflux Oesophagitis |
3.1% |
| Hypokalaemia |
3.0% |
| Cheilitis |
2.9% |
| Asthenopia |
2.2% |
| Pain |
1.8% |
|
| Subileus |
27.1% |
| Pyrexia |
15.9% |
| Vomiting |
12.4% |
| Dysplasia |
4.7% |
| Disease Progression |
3.5% |
| Pneumonia |
3.5% |
| Nephrotic Syndrome |
2.9% |
| Pain |
2.9% |
| Thrombocytopenia |
2.9% |
| Upper Respiratory Tract Infection |
2.9% |
| Aortic Dissection |
2.4% |
| Febrile Neutropenia |
2.4% |
| Metastases To Bone |
2.4% |
| Neoplasm Malignant |
2.4% |
| Tachycardia |
2.4% |
| Wound Treatment |
2.4% |
| Condition Aggravated |
1.8% |
| Constipation |
1.8% |
| Hypophosphataemia |
1.8% |
| Intestinal Perforation |
1.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.6% |
| Breast Cancer |
8.9% |
| Lung Neoplasm Malignant |
8.9% |
| Neuroendocrine Carcinoma |
8.9% |
| Product Used For Unknown Indication |
6.7% |
| Cough |
4.4% |
| Heart Transplant |
4.4% |
| Metastatic Neoplasm |
4.4% |
| Neoplasm Malignant |
4.4% |
| Non-small Cell Lung Cancer |
4.4% |
| Stomatitis |
4.4% |
| Colon Cancer |
2.2% |
| Colorectal Cancer |
2.2% |
|
| Pulmonary Embolism |
21.4% |
| Oedema Peripheral |
14.3% |
| Pyrexia |
14.3% |
| Abdominal Distension |
7.1% |
| Disease Progression |
7.1% |
| Gastroenteritis |
7.1% |
| Nausea |
7.1% |
| Pancreatitis Acute |
7.1% |
| Pleural Effusion |
7.1% |
| Vomiting |
7.1% |
|
